I’m Emily Layton.

A Science Communication enthusiast.

Hi, I'm Emily.

Lorem ipsum dolor sit amet, cons ctetur adipisng elit, seled do eiumod tempor incidnt uhgt labore reliut dolore magna aliqua.

SCIENCE

Research Experience

Previous
Next

2016-2020

Undergraduate Researcher

Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN

Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research 

• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio) 

• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS) 

• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)

May 2019

Research Intern

ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN

Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.

Previous
Next
Previous
Next

2016-2020

Undergraduate Researcher

Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN

Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research 

• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio) 

• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS) 

• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)

May 2019

Research Intern

ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN

Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.

Previous
Next
Previous
Next

2016-2020

Undergraduate Researcher

Dr. Seth Bordenstein’s Lab at Vanderbilt University, Nashville, TN

Funded by SyBBURE Research Program and NSF’s Tennessee Louis Stokes Alliance for Minority Participation in Research 

• Discovered a novel influence on cytoplasmic incompatibility strength and uncovered Wolbachia density and transmission dynamics in Drosophila females (independent project, Layton et al. 2019, mBio) 

• Identified the Wolbachia gene responsible for rescue of cytoplasmic incompatibility (coauthored Shropshire et al. 2018, PNAS) 

• Elucidated the Wolbachia genes responsible for cytoplasmic incompatibility (coauthored LePage et al. 2017, Nature)

May 2019

Research Intern

ImmunoBiochem Corporation of Johnson & Johnson’s JLABS, Toronto, Ontario, CN

Investigated the advantages and complications of current CAR-T immunotherapies in
overcoming solid tumor heterogeneity and tumor penetration.

Previous
Next